Performance of the OptiMAL® dipstick in the diagnosis of malaria infection in pregnancy by Tagbor, Harry et al.
© 2008 Tagbor et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article 
which permits unrestricted noncommercial use, provided the original work is properly cited.
Therapeutics and Clinical Risk Management 2008:4(3) 631–636 631
ORIGINAL RESEARCH
Performance of the OptiMAL® dipstick in 
the diagnosis of malaria infection in pregnancy
Harry Tagbor1
Jane Bruce2
Edmund Browne1
Brian Greenwood2
Daniel Chandramohan2
1Department of Community Health, 
School of Medical Sciences, Kwame 
Nkrumah University of Science 
and Technology, Kumasi, Ghana; 
2Department of Infectious and 
Tropical Diseases, London School 
of Hygiene and Tropical Medicine, 
London, UK
Correspondence: Harry Tagbor
Department of Community Health, 
School of Medical Sciences, Kwame 
Nkrumah University of Science and 
Technology, Private Mail Bag, University 
Post Ofﬁ  ce, Kumasi, Ghana
Tel/Fax +233 51 64236
Email harry.tagbor@lshtm.ac.uk
Abstract: The accuracy of OptiMAL® dipsticks was compared with that of microscopy in 
the diagnosis of malaria infection in pregnancy. During the course of a clinical trial of anti-
malarial drugs in pregnancy, we screened 4500 pregnant women of all parities who accessed 
antenatal clinic services at St. Theresa’s Hospital’s in Nkoranza, Ghana, between March 2003 
and December 2004 with OptiMAL® dipsticks and conﬁ  rmed the diagnosis of malaria with 
microscopy. We determined the sensitivity, speciﬁ  city, positive and negative predictive values, 
and the area under receiver operating characteristic (ROC) curve for the OptiMAL® antigen test 
compared to microscopy for the diagnosis of malaria infection in pregnancy. OptiMAL® dipsticks 
had a sensitivity of 96.6%, speciﬁ  city of 85.4%, a positive predictive value of 92.7%, a negative 
predictive value of 92.6%, and an area under the ROC curve of 0.91 (95% CI of 0.90–0.92). 
The diagnostic accuracy of the OptiMAL® dipstick is high and the test may have practical use 
in the diagnosis of malaria infection in pregnancy in malaria endemic countries.
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Introduction
Early accurate diagnosis and prompt effective treatment of malaria are key components 
of the global malaria control strategy aimed at reducing unnecessary use of antima-
larials but also preventing mortality and reducing morbidity (WHO 2005, 2006a). 
In settings where there are no facilities for laboratory diagnosis clinical diagnosis of 
malaria is recommended and made often based on the presence of fever or history of 
fever. Clinical diagnosis has never been validated and has very low accuracy as signs 
and symptoms of malaria may be non-speciﬁ  c. This results in increased morbidity and 
mortality, and increased transmission of drug-resistant parasite strains associated with 
inappropriate treatment (WHO 2006a). However, parasitological diagnosis ensures high 
speciﬁ  city of malaria diagnosis, prevents unnecessary exposure to antimalarials, and 
helps to save cost on expensive antimalarials including artemisinin-based combination 
therapies (WHO 1999, 2003, 2005, 2006a; Njama-Meya et al 2007).
Methods used for parasitological diagnosis include light microscopy, ﬂ  uorescent 
microscopy, rapid diagnostic tests (RDTs), and polymerase chain reaction (PCR). 
Light microscopy remains the method of choice for parasitological diagnosis of malaria 
worldwide. In comparison to PCR, it is highly sensitive and speciﬁ  c in expert hands at 
parasite densities above 50/µL (Moody 2002). Microscopy is beneﬁ  cial for the iden-
tiﬁ  cation of parasite species, quantiﬁ  cation of parasite density, has lower cost, and is 
highly reproducible (WHO 1999, 2006a). Microscopy has other applications besides 
diagnosis of malaria, such as for the diagnosis of tuberculosis, schistosomiasis, and 
worm infestations. However, lack of expertise, limited supplies, inadequate mainte-
nance of microscopes and reagents, and inadequate quality control make microscopy 
a less reliable technique in remote areas of malaria endemic regions.Therapeutics and Clinical Risk Management 2008:4(3) 632
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Compared to microscopy, RDTs attract very low capital 
costs with little or no maintenance costs. They require only 
minimal training and are rapid, accurate, simple to conduct, 
and applicable in ﬁ  eld and clinical settings in remote areas 
and in emergency situations where expert microscopy may 
not be practical (WHO 2006b). These major advantages of 
RDTs over microscopy notwithstanding, reports of assess-
ments of their diagnostic performance have being inconsis-
tent. Of particular concern is the variability in sensitivity and 
reliability of RDTs at both high and low levels of parasitemia 
and variable sensitivities in different geographic settings 
(Moody 2002; WHO 2006b). The excessive heat and humidity 
in tropical countries are likely to degrade the tests and reduce 
their shelf life. Prolonged exposure to temperatures greater than 
30 °C is likely to reduce sensitivity, necessitating cold chains 
where possible for transport and storage (Moody 2002).
The PCR technique is used to detect sub-microscopic 
levels of parasitemia. It is a highly specialized technique 
requiring expensive equipment and very elaborate labora-
tory settings. It is not applicable to clinical settings but used 
mainly in research settings. It is often used as a standard 
against which the diagnostic accuracy of other parasitological 
methods is determined. Other methods such as ﬂ  uorescent 
microscopy and laser desorption mass spectrometry may be 
used in malaria diagnosis but, like the PCR technique, they 
need special and expensive equipments and logistics and may 
not be applicable to most clinical settings (Moody 2002).
Malaria in pregnancy is a major public health problem 
with adverse consequences for the mother and her baby, par-
ticularly in sub-Saharan Africa (Menendez 1995; Menendez 
et al 2000; Shulman and Dorman 2003). However, the appli-
cation of clinical and parasitological methods to diagnose 
malaria in pregnancy as recommended by the WHO (WHO 
2004) has some challenges which limits the full deployment 
of effective treatment of malaria during pregnancy as a 
control measure. In highly endemic areas, malaria infection 
in pregnancy rarely causes an acute illness which makes 
clinical diagnosis of malaria during pregnancy difﬁ  cult even 
though the infection may progress to cause severe anemia 
particularly in primigravidae. Microscopic diagnosis of 
malaria during pregnancy in women who live in endemic 
areas is limited by sequestration of parasitized red blood cells 
in the placental microcirculation, which reduces the number 
of circulating ring stage parasites detectable in peripheral 
blood by microscopy rendering the method insensitive in 
pregnancy (Mockenhaupt et al 2000) . The PCR technique 
and the laser desorption mass spectrometry (LDMS) may 
be useful for detecting parasitemia in pregnancy (Duffy and 
Fried 2005; Nyunt et al 2005). However, these techniques 
are not applicable in settings where the burden of malaria in 
pregnancy is greatest.
Malaria rapid diagnostic tests (RDTs) detect either 
histidine-rich protein-2 (HRP-2) or plasmodium lactate 
dehydrogenase enzyme (pLDH) (WHO 1999). Several stud-
ies have evaluated HRP-2 based RDTs (Kilian et al 1997; 
Tjitra et al 1999; Singh and Valecha 2000; Tarimo et al 2001; 
Forney et al 2003; Njama-Meya et al 2007) or pLDH based 
RDTs (Cooke et al 1999; Piper et al 1999; Iqbal et al 2003; 
Palmer et al 2003) for the diagnosis of malaria in children 
and non-pregnant adults. A few studies (Leke et al 1999; 
Mankhambo et al 2002; Mockenhaupt et al 2002; Singer et al 
2004) have reported their use in the diagnosis of malaria at 
delivery and/or in the detection of placental malaria. The use 
of RDTs for diagnosing malaria in pregnant women attending 
antenatal clinics has been reported in only one study so far 
(VanderJagt et al 2005). We have, therefore, undertaken a 
study that compared the accuracy of the OptiMAL® antigen 
test for detecting peripheral parasitemia with microscopy in 
pregnant women at the time of presentation at an antenatal 
clinic during the course of a randomized controlled trial 
(RCT) of chloroquine (CQ) amodiaquine (AQ) and sulpha-
doxine-pyrimethamine (SP) for the treatment of malaria in 
pregnancy.
Methods
The study population comprised pregnant women of all 
parities who attended the antenatal clinic at the St. Theresa’s 
Hospital in, Nkoranza, Ghana between March 2003 and 
December 2004. All women who reported at the antenatal 
clinic and were presumed to be pregnant were invited to 
participate in the screening process. Prior to any clinical 
assessment and enrolment, pregnant women were assigned 
sequential screening numbers and screened for malaria infec-
tion using OptiMAL® dipsticks.
The OptiMAL® rapid malaria diagnosis test kits we used 
were bought in batches from the manufacturer, DiaMed 
AG—Cressier, Switzerland under license from Flow, Inc. 
Portland, Oregon, who also organized transportation to the 
study site on each occasion. All test kits were kept at room 
temperature at the study site and opened just before performing 
the test to protect against high humidity. Each test kit comprised 
a dipstick, pipette, conjugate and wash wells, and a dropper 
containing a buffer, sealed together in an aluminium package 
with a desiccant. The tests were performed and interpreted 
according to the manufacturer’s instructions. The four-member 
screening team comprised two senior secondary school and two Therapeutics and Clinical Risk Management 2008:4(3) 633
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polytechnic graduates who had received two weeks’ training 
from the principal investigator (HT) on the conduct and the 
interpretation of test results. Each member had a speciﬁ  c task 
assigned at each antenatal clinic screening session; one member 
performed the dipstick test, another prepared blood slides, one 
was in charge of record keeping, and the fourth member kept 
the time. The record keeper entered screening records on a 
screening form that had ﬁ  elds for the woman’s name, screening 
number, positive results, negative results, and ﬁ  elds to indicate 
whether enrolment took place. For each test, a new OptiMAL® 
kit was assembled. One drop of buffer solution was added to 
the conjugate well ﬁ  rst, followed by adding 10 µL of ﬁ  nger-
prick blood and the content was thoroughly mixed for about 1 
minute. The dipstick was then placed in the conjugate well and 
allowed to stand for 10 minutes while the well content wick 
up the dipstick. The dipstick was then transferred to the wash 
well containing four drops of the buffer solution and allowed 
to wash for another 10 minutes. Then the reaction bands on 
the dipstick were read and interpreted.
Positive results were indicated by the presence of more 
than one red colored reaction bands on the dipstick. The 
top, middle and bottom reaction bands represented an 
internal control band, a pan-plasmodium-speciﬁ  c band and 
a Plasmodium falciparum-speciﬁ  c band respectively. The 
appearance of two test bands and one control band together 
indicated a P. falciparum infection; one middle test band and 
one control band indicated a P. vivax, P. malariae or P. ovale 
infection; one control band only at the top of the test strip 
was regarded as a negative test. A test with no reaction bands 
was considered invalid.
The screening team prepared thin and thick blood smears 
for each pregnant woman from a ﬁ  nger prick blood sample 
immediately after obtaining a sample for the OptiMAL® test. 
Blood slides of women who had a positive OptiMAL® test 
together with a set of randomly selected slides of women who 
had a negative OptiMAL® test were examined by a micros-
copist blinded to the OptiMAL® test result. The negative 
OptiMAL® test slides were selected using the serial screen-
ing numbers of negative OptiMAL® test results. Every ﬁ  fth 
number was selected and the corresponding slide examined 
along with the positive test slides obtained during each 
screening session. A blood slide was deemed to be negative 
only when examination of 100 high power ﬁ  elds of a thick 
ﬁ  lm did not show the presence of sexual or asexual forms of 
P. falciparum. A randomly selected sample of 10% of both 
negative and positive slides was re-examined by a micros-
copist (CA) at the Noguchi Memorial Institute of Medical 
Research for quality assurance.
Stata (version 8.1) software was used to clean and validate 
data and to calculate the test validation features according 
to deﬁ  ned standards (Altman and Bland 1994a, b, c; Deeks 
and Altman 2004). For the slides that were re-examined by 
a second microscopist, an interobserver variability in the 
interpretation of microscopy results was computed using the 
kappa statistic including 95% conﬁ  dence intervals (CI).
The clinical trial on which this study was based was 
approved by the ethics committee of the London School of 
Hygiene and Tropical Medicine and by the Health Research 
Unit of the Ministry of Health of Ghana It was registered 
on the NIH Clinical trials register and assigned the number 
NCT00131703.
Results
The overall prevalence of peripheral parasitemia among 
antenatal clinic attenders was 22%, with monthly variations 
ranging from 9% to 32% in 2003 and from 16% to 34% in 
2004. The prevalence of parasitemia peaked in June, July 
and August in 2003 (the rainy season) but no seasonality was 
observed in 2004. The main parasite species detected was 
P. falciparum; no mixed infections were detected in the study 
population either by OptiMAL® test or microscopy.
A total of 6370 OptiMAL® tests were performed on 
4500 pregnant women, 1338 (21%) tests were positive 
and 5032 were negative (Figure 1). Ninety-four slides of 
1281 OptiMAL® positive women assessed microscopically 
were negative while 44 (7.3%) of 598 slides obtained from 
OptiMAL® test negative women were positive on micros-
copy. Fifty-seven women who had a positive OptiMAL® test 
Figure 1 Study proﬁ  le.
6370 Optimal tests conducted 
5032 negatives  1338 positives 
Microscopy on 1281  
1187 positive  94 negative 
Microscopy on 598 
44 positive  554 negative 
51 no
microscopy
4434 no
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did not have a blood slide collected because they declined 
consent before further samples could be taken or the screen-
ing process completed.
Inter-observer variability in reading blood slides by 
microscopists from the St. Theresa’s Hospital and Noguchi 
Memorial Institute of Medical Research was minimal (kappa 
0.34; 95% CI 0.19–0.49).
Low parity, gravidity, and age were associated sig-
niﬁ  cantly with positive dipstick tests (p   0.001) (data not 
shown). Nulliparous women (RR = 3.3; 95% CI, 3.0–3.7) 
and primiparous women (RR = 1.8; 95% CI, 1.5–2.0) 
respectively were more likely to have positive dipstick tests 
compared to multiparous women. Similarly primigravidae 
(RR = 3.2; 95% CI, 2.9–3.6) and secundigravidae (RR = 1.9; 
95% CI, 1.7–2.2) were more likely than multigravidae to 
have positive dipstick results. Pregnant women less than 30 
years of age were more likely than those 30 years or above 
to have positive dipstick results (RR = 2.4; 95% CI, 2.1–2.6). 
Gestational age at screening appears to be associated with 
a positive dipstick test result (p = 0.01); but there was no 
difference testing positive between women screened in their 
second trimester and those screened in their third trimester 
(RR = 1.1; 95% CI, 1.0–1.2).
The diagnostic accuracy of the OptiMAL® dipstick 
increased with increasing density of parasitemia (Tables 
1 and 2). The sensitivity of the test was 57.1%, with a speciﬁ  c-
ity of 93.3% if parasitemia was below 50/µL. However, for 
parasite densities above 50/ µL, the sensitivity and speciﬁ  city 
of the test were 100% and 93.3%, respectively. The predictive 
values increased with higher parasite density. The area under 
a non-parametric receiver operating characteristic (ROC) 
curve comparing the performance of OptiMAL dipsticks 
with microscopy in the diagnosis of malaria in pregnancy 
was 0.91 (0.9–0.92).
Discussion
This study has shown that the OptiMAL® dipstick was able to 
identify more than 90% of pregnant women with peripheral 
blood malaria parasitmia and correctly labeled about 85% 
of non-parasitemic pregnant women. However, the test per-
formed poorly if the parasite density was below 50/µL.
A limitation of this study was the use of peripheral 
blood microscopy as the “gold standard” for the diagnosis 
of malaria infection. The accuracy of a diagnosis based on 
microscopy depends heavily on the expertise of the micros-
copist. However, the study microscopists were very experi-
enced and there was good agreement between the ﬁ  rst and 
second microscopist. A more serious constraint is that it is 
known that there may be malaria infection of the placenta in 
the absence of peripheral blood parasitemia (Mockenhaupt 
et al 2000, 2002) and, in contrast to studies which have 
investigated women at the time of delivery, we were unable 
to determine whether the placenta was infected. It is possible 
that in the case of some women with a positive OptiMAL® test 
but a negative blood ﬁ  lm, the RDT was detecting a placental 
malaria infection.
Studies of the use of rapid diagnostic tests in pregnant 
women have been undertaken mainly for the purpose of 
diagnosing placental malaria at delivery (Leke et al 1999; 
Mankhambo et al 2002; Singer et al 2004). All of these 
studies reported the tests as having good diagnostic features 
apart from one (Mankhambo et al 2002), which casts doubts 
on the sensitivity of the OptiMAL® test for diagnosing pla-
cental malaria. A recently published study which reported 
the use of OptiMAL® dipsticks in the diagnosis of malaria 
in pregnant women who were attending antenatal clinics in 
Nigeria (VanderJagt et al 2005) found the test to be insensi-
tive compared to microscopy and PCR. However, it is not 
possible to compare the results of this study to ours because 
the authors did not report the sensitivity, speciﬁ  city, predic-
tive values, or likelihood ratios, the indicators required for 
comparing the performance of diagnostic tests.
The OptiMAL® dipstick test is expected to produce 
similar results in all environments if the test is conducted 
according to the manufacturer’s instructions. However, we 
found that during the dry months of the year, the wash well 
Table 1 The performance of the OptiMAL® test versus peripheral microscopy in the diagnosis of malaria infection in pregnancy
 Microscopy
 Parasite  level   50/µL Parasite  level  50–100/µL Parasite  level   100/µL Overall  assessment
  Positive  Negative Total Positive Negative Total Positive Negative Total Positive Negative Total
OptiMAL® test 
Positive  24  9  33 68  9  77 822  9  831  1187 94  1281
Negative  18  125  143 0  125  125 0  125  125 44  554  598
Total  42  134 176  68 134 202  822  134 956  1231  648 1879Therapeutics and Clinical Risk Management 2008:4(3) 635
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dried up too soon if the manufacturer’s instruction of ﬁ  lling 
this well at the beginning of the test process was followed. 
Under these conditions, optimum results were obtained 
when the wash well was ﬁ  lled just before the dipstick was 
transferred into it.
Screening with the OptiMAL® dipsticks ﬁ  tted well into 
the routine of the antenatal clinic schedule and use of the 
RDT caused minimal disruptions to the ﬂ  ow of work at the 
clinic throughout the study period. In the past, the high cost 
of RDT kits (US$1.00 to US$3.50 per test) compared to the 
cost of US$0.40 for microscopy (Hanson et al 2004) coupled 
with the availability of relatively cheap and sensitive drugs 
(chloroquine and sulphadoxine-pyrimethamine [SP]) for 
treatment of malaria has been used to argue that RDT use in 
moderate to high transmission areas may not be cost effec-
tive (Wongsrichanalai 2001; Fernando et al 2004; Hanson 
et al 2004). However, in Ghana the average costs of micro-
scopic diagnosis of malaria charged by public and mission 
hospitals in the Brong Ahafo region during the study period 
were 10,000 and 15,000 cedis (approximately US$1.1 and 
US$1.6, respectively) more than the US$1.00 cost per test of 
the OptiMAL® dipstick used in the present study. Thus, cost 
may no longer be an issue limiting the wider use of RDTs in 
routine health care in Ghana. However the fact that RDTs 
are not quantitative is a limiting factor (Wongsrichanalai 
2001). Furthermore, it is not clear to what extent antenatal 
rapid antigen tests results can predict placental parasitemia. 
Nevertheless, RDTs appear more sensitive in detecting 
sub microscopic parasitemia in pregnancy and probably 
placental parasitemia compared to traditional microscopy 
(Mockenhaupt et al 2002).
Since resistance to SP is increasing and an effective 
and safe antimalarial drug to replace SP for intermittent 
preventive treatment is yet to be identiﬁ  ed it is worthwhile 
considering the option of detecting malaria infection using 
rapid diagnostic tests and treating only those who are infected 
with an effective antimalarial drug combination as opposed 
to giving an antimalarial to all pregnant women attending 
an antenatal clinic. In this context the use of OptiMAL® 
dipsticks to detect circulating pLDH may be of public health 
signiﬁ  cance. Antenatal RDT screening and treatment of only 
those with positive results would: (1) reduce unnecessary 
antimalarial drug use, thus offsetting the cost of using rapid 
diagnostic tests (Hanson et al 2004); (2) reduce drug pres-
sure, which is implicated in the spread of parasite resistance 
to antimalarial drugs (Wernsdorfer 1994; Wongsrichanalai 
2001); (3) limit exposure of pregnant women to the newer 
and more expensive antimalarial drugs only to those who are 
infected. It is worthwhile examining the effects of restrict-
ing effective malaria treatment to those who are found to be 
infected with malaria during antenatal.
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